ClinicalTrials.govpublic full text
Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis
psoriatic arthritis, secukinumab, adalimumab, monoclonal antibody, caspar, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888537
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.